Lenette Lu, M.D., Ph.D.

Internal Medicine - Infectious Diseases and Geographic Medicine

New Patient Appointment or 214-645-8300

Education & Training

Medical School - Case Western Reserve University (2006-2010)
Graduate School - Case Western Reserve University (2002-2009), Molecular Virology
Fellowship - Massachusetts General Hospital (2013-2015), Infectious Diseases
Residency - New York Presbyterian Hospital, Cornell Campus (2010-2013), Internal Medicine

Books & Publications

Publications
- Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
  Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Le Van H, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, Lin PL, Lu LL, Maartens G, Owen A, Protopopova M, Rengarajan J, Rubin E, Salgame P, Schurr E, Seddon JA, Swindells S, Tobin DM, Udwadia Z, Walzl G, Srinivasan S, Rustomjee R, Nahid P, American journal of respiratory and critical care medicine 2019 Mar 199 5 564-571
- Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
  Hansen SG, Zak DE, Xu G, Ford JC, Marshall EE, Malouli D, Gilbride RM, Hughes CM, Ventura AB, Ainslie E, Randall KT, Selseth AN, Rundstrom P, Herlache L, Lewis MS, Park H, Planer SL, Turner JM, Fischer M, Armstrong C, Zweig RC, Valvo J, Braun JM, Shankar S, Lu L, Sylwester AW, Legasse AW, Messerle M, Jarvis MA, Amon LM, Aderem A, Alter G, Laddy DJ, Stone M, Bonavia A, Evans TG, Axthelm MK, Früh K, Edlefsen PT, Picker LJ, Nature medicine 2018 02 24 2 130-143
- A Functional Role for Antibodies in Tuberculosis.
  Lu LL, Chung AW, Rosebrock TR, Ghebremichael M, Yu WH, Grace PS, Schoen MK, Tafesse F, Martin C, Leung V, Mahan AE, Sips M, Kumar MP, Tedesco J, Robinson H, Tkachenko E, Draghi M, Freedberg KJ, Streeck H, Suscovich TJ, Lauffenburger DA, Restrepo BI, Day C, Fortune SM, Alter G, Cell 2016 Oct 167 2 433-443.e14
- Mutations in SID2, a novel gene in Saccharomyces cerevisiae, cause synthetic lethality with sic1 deletion and may cause a defect during S phase.
  Jacobson MD, Muñoz CX, Knox KS, Williams BE, Lu LL, Cross FR, Vallen EA, Genetics 2001 Sep 159 1 17-33
- IFN-?-independent immune markers of Mycobacterium tuberculosis exposure.
  Lu LL, Smith MT, Yu KKQ, Luedemann C, Suscovich TJ, Grace PS, Cain A, Yu WH, McKitrick TR, Lauffenburger D, Cummings RD, Mayanja-Kizza H, Hawn TR, Boom WH, Stein CM, Fortune SM, Seshadri C, Alter G, Nature medicine 2019 06 25 6 977-987
- The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.
  Coler RN, Day TA, Ellis R, Piazza FM, Beckmann AM, Vergara J, Rolf T, Lu L, Alter G, Hokey D, Jayashankar L, Walker R, Snowden MA, Evans T, Ginsberg A, Reed SG, NPJ vaccines 2018 3 34
- Introduction: Physician-Scientists in the Evolving Landscape of Biomedical Research.
  Lu LL, Kwon DS, Barczak AK, The Journal of infectious diseases 2018 Aug 218 suppl_1 S1-S2
- Beyond binding: antibody effector functions in infectious diseases.
  Lu LL, Suscovich TJ, Fortune SM, Alter G, Nature reviews. Immunology 2018 Jan 18 1 46-61
- Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1.
  Lu LL, Puri M, Horvath CM, Sen GC, The Journal of biological chemistry 2008 May 283 21 14269-76
- An Inflammatory Story: Antibodies in Tuberculosis Comorbidities.
  McLean MR, Lu LL, Kent SJ, Chung AW, Frontiers in immunology 2019 10 2846
- Publisher Correction: IFN-?-independent immune markers of Mycobacterium tuberculosis exposure.
  Lu LL, Smith MT, Yu KKQ, Luedemann C, Suscovich TJ, Grace PS, Cain A, Yu WH, McKitrick TR, Lauffenburger D, Cummings RD, Mayanja-Kizza H, Hawn TR, Boom WH, Stein CM, Fortune SM, Seshadri C, Alter G, Nature medicine 2019 Jun
- Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.
  Lu LL, Das J, Grace PS, Fortune SM, Restrepo BI, Alter G, The Journal of infectious diseases 2020 Feb

New Patient Appointment or 214-645-8300 or 817-882-2700